Steam Inhalation and Saline Rinses

Table of Contents

1. Why Mechanical Interventions Work
2. The ELVIS Trial — Hypertonic Saline and Household Transmission
3. The Hypochlorous Acid (HOCl) Mechanism
4. Neti Pot, Squeeze Bottle, Powered Irrigators
5. Step-by-Step Irrigation Technique
6. Hypertonic vs Isotonic — What Concentration Works
7. The Sterile Water Rule (Naegleria fowleri)
8. Steam Inhalation
9. Gargling with Salt Water
10. Eucalyptus and Tea Tree Adjuncts
11. Room Humidification and Hygiene
12. Key Research Papers
13. Connections
14. Featured Videos

Why Mechanical Interventions Work

The pathophysiology of upper respiratory infection has a strong mechanical component that is often overlooked. The virus enters via the nasal or oropharyngeal mucosa, replicates locally in the columnar epithelium, and triggers a host inflammatory response that produces three main symptom-generating effects: (1) increased mucus secretion from goblet cells, (2) vasodilation and tissue edema producing nasal congestion, and (3) cytokine-driven malaise and fatigue.

Mechanical interventions address all three at the point of action.

• Physical removal of viral particles and inflammatory mediators. Saline irrigation washes infected mucus, suspended virions, allergens, and inflammatory cytokines (interleukin-6, IL-8, histamine) out of the nasal cavity, paranasal sinuses, and nasopharynx. This reduces the local viral load and the local inflammatory signal.
• Restoration of mucociliary clearance. Thick infected mucus and the swollen mucosal lining of an acute URI impair ciliary function. Saline thins the mucus and reduces edema, restoring the cilia's ability to sweep trapped material toward the pharynx for swallowing.
• Reduction of host inflammatory load. Less viral load and less retained inflammatory exudate translates into less ongoing inflammatory stimulus and less symptom burden.
• Direct viral inhibition via HOCl. The hypertonic saline-to-HOCl conversion (see below) adds a biochemical antiviral mechanism on top of the mechanical one.

This explains why mechanical interventions can have effect sizes (1–2 day reduction in symptom duration, ~35% reduction in household transmission in ELVIS) comparable to oseltamivir, despite involving no pharmacologic agent.

Back to Table of Contents

The ELVIS Trial — Hypertonic Saline and Household Transmission

The Edinburgh and Lothian Viral Intervention Study (ELVIS) was a pilot, open-label (unblinded) randomized controlled trial conducted by Sandeep Ramalingam and colleagues at the University of Edinburgh. The pilot results were published in Scientific Reports in 2019.

Sixty-eight adults with symptoms of new-onset URI for less than 48 hours were randomized to hypertonic saline nasal irrigation plus saltwater gargling (HSNIG, short for hypertonic saline nasal irrigation and gargling) versus usual standard care (control arm). Participants made their own hypertonic saline with sea salt, a measuring spoon, bowls and a flask supplied by the trial, choosing the strongest concentration they found comfortable from 3%, 2.5%, 2.0% and 1.5% (80% used 3%). They were asked to irrigate and gargle as often as needed, expected to be up to 6 times a day for the first two days and less often from day 3; in practice they did so a median of three times a day for a median of 5 days.

Results.

• Illness duration: participants kept their symptom diary for a mean of 6.8 days in the HSNIG arm vs 8.7 days in the control arm, a 1.9-day reduction (p=0.01); counting to the first day participants felt well, the means were 6.0 vs 8.0 days.
• Over-the-counter medication use: 36% lower in the HSNIG arm.
• Time off work: 3 of 28 (11%) in the HSNIG arm vs 7 of 29 (24%) in the control arm took time off — a difference that was not statistically significant (p=0.297).
• Household transmission (any other family member developing URI within the index case's symptomatic window): 35% lower in the HSNIG arm (p=0.006).
• Viral shedding: lower in the HSNIG arm by at least 0.5 log10 per day (p=0.04).
• Acceptability: 87% of the HSNIG arm found it acceptable.

The household-transmission finding drew the most attention. If a larger trial confirms it, it would suggest that a person with a cold who uses saline irrigation does not merely shorten their own illness but also protects the other people in their home — possibly by reducing the duration and intensity of viral shedding.

What ELVIS could not show: it was a pilot whose primary goal was to test whether recruitment worked, not to prove a benefit, and the authors note it was not powered for its efficacy results. It was unblinded, it had no placebo group, follow-up data came from 61 people, and symptoms were self-reported. The authors wrote: “We hence need a larger trial to confirm our findings.”

The earlier Cochrane review by King et al. (2015) covering five small trials of saline irrigation for acute URI (544 children and 205 adults) found that most results showed no difference between nasal saline and the comparison treatment; one larger trial in children found small reductions in nasal secretion and blockage scores that may have minimal clinical significance, and less decongestant use. The reviewers concluded that nasal saline “possibly has benefits” but that the trials were generally too small and at high risk of bias; minor nasal discomfort was reported. The ELVIS pilot adds a small, unblinded trial with a household-transmission result that still needs confirming.

A much larger trial has since been published. In a 2024 UK trial run through 332 general practices, 13,799 adults at higher risk from respiratory infections (for example from heart or lung disease, diabetes, obesity or age 65 and over) or with frequent infections were randomized to usual care, a saline nasal spray, a gel-based nasal spray, or a website on physical activity and stress. The spray groups were told to use two sprays per nostril at the first sign of an infection or after possible exposure, up to 6 times a day. Over 6 months, people in the usual-care group had a mean of 8.2 days of illness, compared with 6.4 days in the saline spray group (incidence rate ratio 0.81), and antibiotic use was lower in the saline spray group (rate ratio 0.69). Headache or sinus pain was not more common with the saline spray (4.5% vs 4.8% with usual care). The trial was open-label, and this was a simple nasal spray rather than full irrigation.

Back to Table of Contents

The Hypochlorous Acid (HOCl) Mechanism

Ramalingam and colleagues published a 2018 paper in Scientific Reports proposing and demonstrating a biochemical mechanism that may explain part of the saline-irrigation benefit. The proposal: respiratory epithelial cells (and other non-myeloid cells) take up chloride ions from the surrounding fluid, and use them to produce intracellular hypochlorous acid (HOCl) — the same molecule that neutrophils produce as part of the respiratory burst to kill ingested pathogens.

HOCl is a potent broad-spectrum antimicrobial, active against bacteria, fungi, and enveloped and non-enveloped viruses. In the Ramalingam 2018 work, increasing chloride availability in the cell culture medium increased intracellular HOCl production and reduced replication of multiple respiratory viruses (influenza A, respiratory syncytial virus (RSV), etc.) in dose-dependent fashion.

The implication is that hypertonic saline irrigation works not just by mechanical washout but by delivering extra chloride substrate to the respiratory epithelium, augmenting the natural intracellular antiviral burst. This is mechanistically elegant: it would explain why hypertonic saline (more chloride per volume than isotonic) might outperform isotonic, and why the irrigation effect persists for hours after the irrigation event itself (the intracellular HOCl production continues with the elevated chloride substrate available).

This mechanism remains hypothetical at the human-population level but provides a coherent rationale for the ELVIS trial findings.

Back to Table of Contents

Neti Pot, Squeeze Bottle, Powered Irrigators

Three principal delivery devices are used for nasal saline irrigation, with different trade-offs.

Neti pot

The traditional Ayurvedic teapot-shaped vessel. Solution flows by gravity from one nostril, through the nasal cavity, and out the other nostril. Low-pressure and gentle. Easiest to learn but somewhat less effective at reaching the deeper sinuses than positive-pressure devices. Plastic neti pots cost $5–$15; ceramic versions are slightly more expensive but more attractive on the bathroom counter.

Squeeze bottle

Soft plastic bottle with an angled nozzle, used with saline packets that are added to lukewarm water. A gentle squeeze delivers positive-pressure flow into one nostril. Generally more effective than gravity neti pots at clearing the maxillary and frontal sinuses and at reaching the nasopharynx. This is the format most often used in randomized trials of nasal irrigation. A squeeze-bottle saline rinse kit is widely available, with replacement saline packets.

Powered/pulsatile irrigator

Powered nasal irrigation devices deliver pulsed positive-pressure saline flow. They are used mainly by people with chronic sinusitis who irrigate daily year-round, rather than for a routine cold or flu.

For acute URI, the squeeze bottle combines positive-pressure flow with low cost and simple use; the neti pot is the simplest gravity option for new users; powered nasal irrigation devices are mostly used when chronic sinus disease is also being managed.

Back to Table of Contents

Step-by-Step Irrigation Technique

The usual method, as described in irrigation instructions:

1. The saline solution. One of: (a) commercial saline packet dissolved in 8 oz lukewarm sterile water, (b) homemade solution of 1/4 teaspoon non-iodized salt plus 1/4 teaspoon baking soda in 8 oz lukewarm sterile water, or (c) commercial pre-mixed saline solution.
2. Position. The person stands over a sink, leans forward, and tilts the head sideways about 45 degrees, with the lower ear roughly parallel to the floor.
3. Nozzle. The nozzle rests gently against the upper nostril, forming a comfortable seal without being pushed deep.
4. Breathing. Breathing goes through the open mouth, not the nose, during irrigation, which keeps the solution from being inhaled.
5. Flow. A gentle squeeze (or a tilt of the neti pot) sends saline in through the upper nostril and out through the lower one, usually until about half the bottle (4 oz) has flowed through.
6. Other side. After a pause and a gentle nose-blow (with the nostrils not pinched closed), the irrigation is repeated on the other side with the head tilted the other way.
7. Clearing. Leftover solution is sniffed to the back of the throat and spat out, or blown out gently; some keeps draining for 5–10 minutes.
8. Cleaning. The device is rinsed and air-dried (see the hygiene section below).

In the ELVIS trial, people with a cold irrigated a median of three times a day (up to six times a day was expected for the first two days). For prevention or chronic sinus management, once daily is typical.

Back to Table of Contents

Hypertonic vs Isotonic — What Concentration Works

Two saline concentrations are commonly used.

• Isotonic (0.9% sodium chloride, the same osmolarity as blood): the standard saline used in intravenous (IV) bags and commercial nasal sprays. Comfortable, well-tolerated, effective for general moisturization and mild mucus thinning.
• Hypertonic (1.5–3.0% sodium chloride, more salt than blood): draws fluid out of the swollen nasal mucosa by osmotic gradient, reducing edema and improving airflow. More aggressive mucus thinning. Slightly more uncomfortable on first use (a brief "burning" sensation that fades with use). ELVIS participants chose between 1.5% and 3%, and 80% used 3%.

For the common cold itself, the head-to-head evidence is thin. In the 1998 trial by Adam and colleagues (119 adults with a cold or sinus infection), a hypertonic saline spray did not improve nasal symptoms or illness duration compared with normal saline or no spray; 32% of the hypertonic group noted burning versus 13% on normal saline, and only 44% said they would use the hypertonic spray again. ELVIS used hypertonic saline but had no isotonic comparison arm.

For rhinitis and sinusitis, a 2018 meta-analysis by Kanjanawasee and colleagues pooled 9 trials (740 patients) comparing hypertonic with isotonic saline irrigation. Hypertonic saline improved symptoms more (standardized mean difference -0.58) but made no difference to a sinus-specific quality-of-life score, and it caused more minor side effects; no serious side effects were reported. Concentrations below 3% and between 3% and 5% helped symptoms, while concentrations above 5% lost the benefit. These were trials in rhinitis and sinus disease, not the common cold.

A typical homemade hypertonic solution: 1/4 teaspoon non-iodized salt plus 1/4 teaspoon baking soda in 8 oz lukewarm sterile water. The strength of a home recipe depends on how much salt a spoonful actually holds, so its percentage is not exact; the ELVIS trial itself used 1.5–3% sea-salt solutions, most often 3%. The baking soda raises the pH closer to physiologic and reduces mucosal irritation.

Back to Table of Contents

The Sterile Water Rule (Naegleria fowleri)

The single most important safety fact for nasal irrigation: untreated tap water is not safe to put up the nose. Multiple documented fatalities have occurred from primary amoebic meningoencephalitis caused by Naegleria fowleri, a thermophilic free-living amoeba that can be present in low concentrations in municipal water supplies. The amoeba is harmless if swallowed (stomach acid kills it) but if introduced into the nasal cavity, it can migrate along the olfactory nerve and into the brain, causing a near-uniformly fatal meningoencephalitis.

Yoder et al. published a 2012 U.S. Centers for Disease Control and Prevention (CDC) report in Clinical Infectious Diseases documenting two Louisiana deaths from this exact mechanism in people using neti pots with tap water. Further deaths have been reported since.

The U.S. Centers for Disease Control and Prevention recommendation is unambiguous: use only water that has been boiled and cooled (boil for at least one minute, three minutes at altitudes above 6,500 feet), distilled, or filtered through a filter rated for ≤1 micron absolute pore size (specifically rated as "NSF Standard 53" or "NSF Standard 58" for cyst removal). Commercial bottled distilled water is widely available, inexpensive, and the simplest reliable choice.

This is not a hypothetical concern: it is a documented cause of death, which is why the CDC guidance excludes untreated tap water from any U.S. or international municipal supply for nasal irrigation.

Back to Table of Contents

Steam Inhalation

Steam inhalation has a long folk tradition, but its trial evidence is limited. The 2017 Cochrane review by Singh et al. on heated humidified air for the common cold included six trials with 387 participants; results for symptom relief depended on the statistical method used, and the reviewers concluded that “the current evidence does not show any benefits or harms from the use of heated, humidified air” delivered by the device tested. The technique remains widely used because it is inexpensive and many people report subjective symptom relief.

Mechanism: warm humidified air thins nasal and tracheal mucus, may temporarily reduce mucosal edema by relaxing capillary smooth muscle, and provides comforting sensory relief from the dry, congested sensation typical of an acute URI. Theoretical: elevated temperature in the nasal cavity may modestly slow rhinoviral replication, which is optimized for 33°C and reduced at 37°C+.

Tyrrell and colleagues tested this idea in a 1989 double-blind trial in the BMJ, in which people breathed fully humidified air heated to 43°C or, as the comparison, 30°C. General-practice patients treated once for 20 minutes at 43°C had roughly half the symptom scores over the following days, and volunteers treated for 30 minutes on three occasions as a cold began had 18% fewer symptoms; but volunteers treated for 20 minutes at onset and 10 minutes on later days showed no difference. These mixed results are part of why later reviews call the evidence inconsistent.

Steam-tent technique

The traditional home method:

1. 2–3 cups of water are brought to a boil in a pot or kettle.
2. The water is poured carefully into a heat-safe bowl.
3. A large towel is draped over the head and the bowl to form a "tent."
4. The person leans over the bowl at a distance (starting further away and moving closer as the water cools) and breathes the warm vapor for 5–10 minutes.
5. Some people add 2–3 drops of eucalyptus or peppermint essential oil to the water.
6. It is commonly repeated 2–3 times a day.

Burn safety: several pediatric case series have documented serious facial scald injuries from steam-tent technique done with very hot water and children. The water in the bowl is close to boiling, so the burns happen when it splashes or the bowl is bumped or tipped. A hot shower with the door closed provides a similar humidified-air exposure without a bowl of near-boiling water.

Back to Table of Contents

Gargling with Salt Water

Saltwater gargling has surprisingly good evidence for both symptom relief and infection prevention. A 2005 randomized trial by Satomura et al. published in the American Journal of Preventive Medicine enrolled 387 healthy Japanese volunteers and randomized them to gargling with water, gargling with povidone-iodine solution, or no gargling, for 60 days during winter. Water gargling reduced URI incidence by approximately 36% compared to no gargling (p=0.03). Povidone-iodine gargling, surprisingly, was not significantly better than no gargling.

For acute URI symptom relief, warm saltwater gargling (1/2 teaspoon salt in 8 oz warm water) several times daily reduces sore-throat pain, helps clear thick pharyngeal mucus, and is essentially free. The mechanism is partly mechanical (washing pathogens and inflammatory exudate from the oropharyngeal mucosa) and partly osmotic (reducing pharyngeal mucosal edema).

The ELVIS trial paired gargling with nasal irrigation in the active arm, so its symptom-duration and household-transmission results reflect the combination; the trial could not separate the effect of gargling from that of irrigation.

Back to Table of Contents

Eucalyptus and Tea Tree Adjuncts

Several volatile essential oils have a long folk tradition as steam-inhalation adjuncts. The most common are eucalyptus (Eucalyptus globulus) and tea tree (Melaleuca alternifolia), with peppermint, rosemary, and thyme also used.

The evidence for these as antiviral agents is weak. The main rationale is subjective: the cooling and clearing sensation from eucalyptol (1,8-cineole) provides perceived decongestion even when objective nasal airway measurements show no change. The 1,8-cineole compound itself has anti-inflammatory and mucolytic activity at high topical concentrations in some studies, providing modest mechanistic support.

Traditional use is 2–3 drops of food-grade eucalyptus or tea tree essential oil in the steam-inhalation water; more concentrated essential-oil vapor can irritate the eyes and respiratory mucosa. Tea tree oil is not for swallowing. Both oils are unsafe for direct application to infant or young-child mucosa (multiple case reports of toxic reactions in babies under 2 years).

Camphor-menthol chest rubs (vapor rubs) contain camphor, menthol, and eucalyptus oil in a petroleum-jelly base and have a longer trial track record than essential oils alone. A 2010 Paul et al. trial in Pediatrics showed vapor rub on the chest improved subjective sleep and symptom scores in children with URI compared with petrolatum placebo. Adults also commonly use these rubs, though that trial was in children.

Back to Table of Contents

Room Humidification and Hygiene

Indoor relative humidity in winter (in heated homes at temperate latitudes) often drops to 15–25%, well below the 40–60% range that maintains comfortable mucosal hydration. Dry mucosa is more susceptible to viral colonization and more symptomatic once infected.

A room humidifier (cool-mist ultrasonic, evaporative, or steam) raises humidity into the 40–50% range and reduces the dry-cough, dry-nose, dry-throat symptoms that accompany acute URI.

Humidifier hygiene is critical. Stagnant water in humidifier reservoirs grows bacteria (including Legionella), mold, and free-living amoebae. These can be aerosolized and inhaled, causing humidifier lung (hypersensitivity pneumonitis), legionellosis, or other respiratory illness. Common hygiene practices:

• Emptying and drying the reservoir daily.
• Cleaning the reservoir with vinegar or dilute bleach solution every 3–7 days.
• Using distilled or filtered water (tap water deposits white mineral dust on furniture and may also seed organisms).
• Replacing the unit's filter element on the manufacturer's schedule.
• Not running a humidifier continuously for weeks without cleaning, which lets organisms build up.

Back to Table of Contents

Key Research Papers

1. Ramalingam S, Graham C, Dove J, Morrice L, Sheikh A. A pilot, open labelled, randomised controlled trial of hypertonic saline nasal irrigation and gargling for the common cold (ELVIS pilot). Sci Rep 2019. — PubMed PMID: 30705369
2. Ramalingam S, Cai B, Wong J, et al. Antiviral innate immune response in non-myeloid cells is augmented by chloride ions via an increase in intracellular hypochlorous acid levels. Sci Rep 2018. — PubMed PMID: 30206371
3. King D, Mitchell B, Williams CP, Spurling GK. Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev 2015. — PubMed PMID: 25892369
4. Slapak I, Skoupa J, Strnad P, Hornik P. Efficacy of isotonic nasal wash (seawater) in the treatment and prevention of rhinitis in children. Arch Otolaryngol Head Neck Surg 2008. — PubMed PMID: 18209140
5. Singh M, Singh M, Jaiswal N, Chauhan A. Heated, humidified air for the common cold. Cochrane Database Syst Rev 2017. — PubMed PMID: 28849871
6. Adam P, Stiffman M, Blake RL Jr. A clinical trial of hypertonic saline nasal spray in subjects with the common cold or rhinosinusitis. Arch Fam Med 1998. — PubMed PMID: 9443697
7. Rabago D, Zgierska A. Saline nasal irrigation for upper respiratory conditions. Am Fam Physician 2009. — PubMed PMID: 19904896
8. Satomura K, Kitamura T, Kawamura T, et al. Prevention of upper respiratory tract infections by gargling: a randomized trial. Am J Prev Med 2005. — PubMed PMID: 16242593
9. Tyrrell D, Barrow I, Arthur J. Local hyperthermia benefits natural and experimental common colds. BMJ 1989. — PubMed PMID: 2500196
10. Yoder JS, Straif-Bourgeois S, Roy SL, et al. Primary amebic meningoencephalitis deaths associated with sinus irrigation using contaminated tap water. Clin Infect Dis 2012. — PubMed PMID: 22919000
11. Paul IM, Beiler JS, King TS, et al. Vapor rub, petrolatum, and no treatment for children with nocturnal cough and cold symptoms. Pediatrics 2010. — PubMed PMID: 21059712
12. Kanjanawasee D, Seresirikachorn K, Chitsuthipakorn W, Snidvongs K. Hypertonic saline versus isotonic saline nasal irrigation: systematic review and meta-analysis. Am J Rhinol Allergy 2018. — PubMed PMID: 29774747
13. Little P, Vennik J, Rumsby K, et al. Nasal sprays and behavioural interventions compared with usual care for acute respiratory illness in primary care: a randomised, controlled, open-label, parallel-group trial. Lancet Respir Med 2024. — PubMed PMID: 39004091

Back to Table of Contents

Connections

• All Remedies
• Benefits Hub
• Cold and Flu Treatments (Main Page)
• Zinc Acetate Lozenges
• Vitamin D Status and Respiratory Infection
• Elderberry and Antiviral Activity
• Immune Boosting
• Pulmonology (Respiratory Diseases)
• Eucalyptus
• Tea Tree
• Peppermint
• Zinc
• Vitamin D3

Back to Table of Contents

Featured Videos

×